InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Greenberg Richard S, Chairman & CEO. Officer active across 1 company, notably Nexien Biopharma, INC.. Cumulatively, 9 filings have been published. Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Greenberg Richard S is President and Chief Executive Officer and Chief Executive Officer of Nexien Biopharma, INC. He has 9 filings in total, and in the 9 sampled filings the recorded transactions are attribution events, with a date range from 2021-11-29 to 2024-05-28.